Pharmaresearch Bio Co (XKRX:217950) Pre-Tax Income : ₩4,640 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Pharmaresearch Bio Co's pretax income for the six months ended in Dec. 2023 was ₩4,640 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,640 Mil. Pharmaresearch Bio Co's pretax margin was 23.17%.

During the past 6 years, Pharmaresearch Bio Co's highest Pretax Margin was 31.75%. The lowest was -26.18%. And the median was 21.84%.

Pharmaresearch Bio Co Pre-Tax Income Historical Data

The historical data trend for Pharmaresearch Bio Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Pre-Tax Income Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-851.22

21.23

2,310.52

3,971.02

4,640.32

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Pre-Tax Income	Get a 7-Day Free Trial			-851.22	21.23	2,310.52	3,971.02	4,640.32

Competitive Comparison of Pharmaresearch Bio Co's Pre-Tax Income

For the Biotechnology subindustry, Pharmaresearch Bio Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaresearch Bio Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's Pre-Tax Income falls into.

Pharmaresearch Bio Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharmaresearch Bio Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	6223.276	+	0	+	-2748.01	+	1581.159	+	-416.105
	=	4,640

Pharmaresearch Bio Co's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	6223.276	+	0	+	-2748.01	+	1581.159	+	-416.105
	=	4,640

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,640 Mil.

Pharmaresearch Bio Co (XKRX:217950) Pre-Tax Income Explanation

Pharmaresearch Bio Co's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	4640.32	/	20030.641
	=	23.17%

During the past 6 years, Pharmaresearch Bio Co's highest Pretax Margin was 31.75%. The lowest was -26.18%. And the median was 21.84%.

Pharmaresearch Bio Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines